DaVita Inc., US23918K1088

DaVita stock gains as 2026 guidance beats estimates

Published on 09/17/2026 at 17:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DaVita stock closed at USD 189.32 on September 14, 2026 after 2026 EPS guidance of USD 14.10 to USD 15.20. The shares last traded at USD 193.86 on September 16, 2026.

Modernes Dialysezentrum mit Pflegepersonal und Patienten in heller Klinikumgebung
DaVita Inc. Dialysezentrum mit modernen Behandlungsstühlen und medizinischem Pflegepersonal in Denver, ISIN US23918K1088, Illustration mit AI erstellt.

DaVita Inc. stock (ISIN US23918K1088) closed at USD 193.86 on September 16, 2026, up 1.55 percent from the prior session and within a 52-week range of USD 101.00 to USD 247.49. The move followed a full-year 2026 earnings outlook of USD 14.10 to USD 15.20 per share that topped the Street's USD 14.57 consensus.

Guidance sets the tone

As Investing.com reported on September 17, 2026, DaVita's 2026 guidance of USD 14.10 to USD 15.20 per share came after the stock jumped 4.28 percent on September 14 to USD 189.32. The same report said the guidance sits above the USD 14.57 consensus and implies about 12.9 times forward earnings on the midpoint.

That valuation matters because the stock has already climbed 10.06 percent since September 1, 2026, while the market cap stood at USD 12.47 billion in the latest quote snapshot. The combination of a higher earnings range and a double-digit September gain explains why the stock stayed near the top of its recent band.

Earnings remain the anchor

According to StockStory on September 17, 2026, DaVita reported revenue of USD 3.55 billion in Q2 2026, up 5.2 percent year on year and 1.7 percent above analyst expectations. The same report said the quarter also beat EPS estimates, even as full-year EPS guidance missed expectations at the time.

For investors, that mix is the key tension: USD 3.55 billion in quarterly revenue and a 5.2 percent increase show operating momentum, but the market is still trading the stock against guidance credibility. The latest consensus EPS estimate of USD 14.57 and revenue of USD 14.28 billion for the full year frame the next comparison point.

Price stays elevated

DaVita stock traded at USD 193.86 on September 16, 2026, with a market capitalization of USD 12.47 billion and a 52-week range of USD 101.00 to USD 247.49. The stock's September 14 close of USD 189.32 and the current level show that the move after guidance has held into the latest session.

DaVita stock at a glance

  • Company: DaVita Inc.
  • ISIN: US23918K1088
  • Ticker: DVA
  • Trading venue: NYSE
  • Price (as of September 16, 2026): USD 193.86
  • Market capitalization: USD 12.47 billion (as of September 17, 2026)
  • Sector / Industry: Health Care / Health Care Providers & Services
  • Index membership: S&P 500

More news and analyses on DaVita stock

Disclaimer...

en | US23918K1088 | DAVITA INC. | boerse | 70118859 | bgmi